95 related articles for article (PubMed ID: 3030956)
1. Superiority of antibody versus delayed hypersensitivity in clearance of HSV-1 from eye.
Lausch RN; Monteiro C; Kleinschrodt WR; Oakes JE
Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):565-70. PubMed ID: 3030956
[TBL] [Abstract][Full Text] [Related]
2. Resolution of HSV corneal infection in the absence of delayed-type hypersensitivity.
Lausch RN; Kleinschradt WR; Monteiro C; Kayes SG; Oakes JE
Invest Ophthalmol Vis Sci; 1985 Nov; 26(11):1509-15. PubMed ID: 2997073
[TBL] [Abstract][Full Text] [Related]
3. The dichotomy between herpes simplex virus type 1-induced ocular pathology and systemic immunity.
Metzger EE; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1533-40. PubMed ID: 3040615
[TBL] [Abstract][Full Text] [Related]
4. The effect of cellular immune tolerance to HSV-1 antigens on the immunopathology of HSV-1 keratitis.
Hendricks RL; Epstein RJ; Tumpey T
Invest Ophthalmol Vis Sci; 1989 Jan; 30(1):105-15. PubMed ID: 2536358
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the antigenic structure of two major HSV-1 glycoproteins, gC and gB, influence immune regulation and susceptibility to murine herpes keratitis.
Hendricks RL; Tao MS; Glorioso JC
J Immunol; 1989 Jan; 142(1):263-9. PubMed ID: 2909617
[TBL] [Abstract][Full Text] [Related]
6. Autologous antibody is protective against HSV-1 infection of the immunocompromised mouse.
Alexander TS; Rosenthal KS
J Lab Clin Med; 1990 Sep; 116(3):400-7. PubMed ID: 2169516
[TBL] [Abstract][Full Text] [Related]
7. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection.
Cheng H; Tumpey TM; Staats HF; van Rooijen N; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1402-9. PubMed ID: 10798656
[TBL] [Abstract][Full Text] [Related]
8. Immunobiology of Langerhans cells on the ocular surface. II. Role of central corneal Langerhans cells in stromal keratitis following experimental HSV-1 infection in mice.
McLeish W; Rubsamen P; Atherton SS; Streilein JW
Reg Immunol; 1989; 2(4):236-43. PubMed ID: 2561960
[TBL] [Abstract][Full Text] [Related]
9. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
Morrison LA; Knipe DM
Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1.
Tumpey TM; Elner VM; Chen SH; Oakes JE; Lausch RN
J Immunol; 1994 Sep; 153(5):2258-65. PubMed ID: 8051423
[TBL] [Abstract][Full Text] [Related]
11. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.
Inoue T; Inoue Y; Nakamura T; Yoshida A; Takahashi K; Inoue Y; Shimomura Y; Tano Y; Fujisawa Y; Aono A; Hayashi K
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4209-15. PubMed ID: 11095617
[TBL] [Abstract][Full Text] [Related]
12. CXCR3, IP-10, and Mig are required for CD4+ T cell recruitment during the DTH response to HSV-1 yet are independent of the mechanism for viral clearance.
Molesworth-Kenyon S; Mates A; Yin R; Strieter R; Oakes J; Lausch R
Virology; 2005 Mar; 333(1):1-9. PubMed ID: 15708587
[TBL] [Abstract][Full Text] [Related]
13. The role of antigen-presenting cells in the regulation of delayed-type hypersensitivity. II. Epidermal Langerhans' cells and peritoneal exudate macrophages.
Morikawa Y; Furotani M; Matsuura N; Kakudo K
Cell Immunol; 1993 Nov; 152(1):200-10. PubMed ID: 8242760
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immune tolerance to HSV-1 antigens associated with reduced susceptibility to HSV-1 corneal lesions.
Ksander BR; Hendricks RL
Invest Ophthalmol Vis Sci; 1987 Dec; 28(12):1986-93. PubMed ID: 2824400
[TBL] [Abstract][Full Text] [Related]
15. The effects of cyclosporin A on the induction, expression and regulation of the immune response to herpes simplex virus.
Altmann DM; Blyth WA
Clin Exp Immunol; 1985 Jan; 59(1):17-22. PubMed ID: 2982525
[TBL] [Abstract][Full Text] [Related]
16. Incidence and severity of herpetic stromal keratitis: impaired by the depletion of lymph node macrophages.
Bauer D; Mrzyk S; Van Rooijen N; Steuhl KP; Heiligenhaus A
Exp Eye Res; 2001 Mar; 72(3):261-9. PubMed ID: 11180975
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccine-encoded glycoprotein B of HSV-1 fails to protect chronic morphine-treated mice against HSV-1 challenge.
Jamali A; Roostaee MH; Soleimanjahi H; Ghaderi Pakdel F; Bamdad T
Comp Immunol Microbiol Infect Dis; 2007 Mar; 30(2):71-80. PubMed ID: 17126902
[TBL] [Abstract][Full Text] [Related]
18. Retinitis and deviant immune responses following intravitreal inoculation of HSV-1.
Atherton SS; Pesicka GA; Streilein JW
Invest Ophthalmol Vis Sci; 1987 May; 28(5):859-66. PubMed ID: 3032839
[TBL] [Abstract][Full Text] [Related]
19. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.
Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M
Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902
[TBL] [Abstract][Full Text] [Related]
20. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
Hazlett LD; McClellan S; Kwon B; Barrett R
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):805-10. PubMed ID: 10711697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
